Literature DB >> 10478628

Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds?

A M Gray1, D M Pache, R D Sewell.   

Abstract

Antidepressants are analgesic in the absence or presence of depression. The underlying mechanisms probably involve a complex interplay between several neurotransmitter systems and neuroreceptors. Alpha-adrenoceptors play an important role in pain processing and alpha2-adrenoceptor agonists have been used in clinical pain management so we have investigated whether alpha-adrenoceptor sub-types mediate the antinociceptive activity of antidepressants. Thus, the abdominal constriction assay in mice was used to examine the antinociceptive responses of a diverse range of antidepressants following alpha1- or alpha2-adrenoceptor antagonism. The antidepressants or monoamine reuptake inhibitors included the serotonin selective reuptake inhibitor paroxetine, the serotonin-noradrenaline reuptake inhibitor sibutramine, the resolved (+)- and (-)-enantiomers of the noradrenaline reuptake inhibitor oxaprotiline, plus the tricyclics amitriptyline and dothiepin. All these compounds have been previously shown to be antinociceptive in this paradigm. The respective alpha1- and alpha2-adrenoceptor antagonists prazosin and RX821002 ([2-(2-methoxy-1,-4-benzodioxan-2-yl)-2-imidazoline]) did not produce antinociception though at 1.0 mg kg(-1); s.c., RX821002 but not prazosin blocked clonidine antinociception. The antinociceptive activity produced by sub-maximal doses of amitriptyline, dothiepin, sibutramine, paroxetine, (+)- and (-)-oxaprotiline were all blocked by RX821002 but not by prazosin. Additionally, both morphine and aspirin antinociception was resistant to alpha1- and alpha2-adrenoceptor antagonism. Thus, alpha2- rather than alpha1-adrenoceptors may play an integral role in antidepressant antinociception irrespective of the propensity for inhibiting reuptake of not only noradrenaline but also serotonin. It is probable, however, that other differing pharmacological properties of some antidepressants, such as opioid-like activity, may complicate any empirical correlation between monoamine uptake and analgesia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478628     DOI: 10.1016/s0014-2999(99)00464-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

Review 1.  Antidepressants as analgesics: an overview of central and peripheral mechanisms of action.

Authors:  J Sawynok; M J Esser; A R Reid
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

Review 2.  Antidepressants as analgesics.

Authors:  Gary McCleane
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  Antinociceptive Effect of Mirtazapine in Rats with Diabetic Neuropathy.

Authors:  Ahmet Inal; Murat Büyükşekerci; Hasan Basri Ulusoy
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

Review 4.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

5.  Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs.

Authors:  Munawar A Munawar; Yeon Sun Lee; David Rankin; Jawaria Munir; Josephine Lai; Misbahul A Khan; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2015-02-03       Impact factor: 3.641

6.  Potentiated opioid analgesia in norepinephrine transporter knock-out mice.

Authors:  L M Bohn; F Xu; R R Gainetdinov; M G Caron
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

7.  Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise.

Authors:  David M Marks; Manan J Shah; Ashwin A Patkar; Prakash S Masand; Geun-Young Park; Chi-Un Pae
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

8.  Phase 1A safety assessment of intravenous amitriptyline.

Authors:  Peter Fridrich; Hans Peter Colvin; Anthony Zizza; Ajay D Wasan; Jean Lukanich; Philipp Lirk; Alois Saria; Gerald Zernig; Thomas Hamp; Peter Gerner
Journal:  J Pain       Date:  2007-05-23       Impact factor: 5.820

9.  Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.

Authors:  Nada Choucair-Jaafar; Ipek Yalcin; Jean-Luc Rodeau; Elisabeth Waltisperger; Marie-José Freund-Mercier; Michel Barrot
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

Review 10.  Antidepressants in long-term migraine prevention.

Authors:  Horst J Koch; Tim P Jürgens
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.